期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

磁共振加权成像在椎体转移瘤放化疗前后表观扩散系数变化的意义(附9例分析) 被引量：2

下载PDF
导出
摘要 目的探讨磁共振扩散加权成像(DWI)在椎体转移瘤放化疗前后表观扩散系数(ADC)变化的意义。方法对9例经病理或放射性核素骨显像证实为转移瘤的9个椎体,接受放化疗前后行常规MRI及DWI检查。测量治疗前后ADC值,按治疗前后ADC值的变化进行分组分析比较。结果治疗后ADC值明显升高,差异有统计学意义(P<0.05)。结论 DWI可以作为椎体转移瘤放化疗早期评价指标,并可根据ADC值升高情况预测治疗效果。
作者 聂晓历 杨海松
机构地区 福建省肿瘤医院放诊科 福建省肿瘤医院放疗科
出处 《福建医药杂志》 CAS 2013年第1期128-130,共3页 Fujian Medical Journal
关键词 磁共振成像 椎体转移瘤 放化疗 表观扩散系数
分类号 R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献7

  • 1Nasu K,Kuroki Y,Nawnao S. Hepatic metastases:Diffusion weighted sensitivity-encoding versus SPIO-enhanced MR imaging[J].Radiology,2006,(09):122-130.
  • 2Naganawa S,Sato C,Nakamura T. Diffusion2 Weighted images of the liver:comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide[J].Magnetic Resonance Imaging,2005,(01):836-840.
  • 3Li S,Sun F,Xue H D. Whole-body diffusion-weighted imaging:technical improvement and preliminary results[J].Journal of Magnetic Resonance Imaging,2007,(04):1139-1144.doi:10.1002/jmri.21074.
  • 4龚红霞,路青,朱炯,范瑜,许建荣.3.0T磁共振弥散加权成像和表观弥散系数在淋巴瘤诊断中的价值[J].上海交通大学学报（医学版）,2008,28(8):944-947. 被引量：18
  • 5Buijs M,Kamel I R,Vossen J A. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion weighted MR imaging[J].Journal of Vascular and Interventional Radiology,2007,(08):957.
  • 6Mardor Y,Roth Y,Ochershvicli A. Pretreatment prediction of brain tumorsresponse to radiation therapy using high hnalue diffusion-weighted MRI[J].Neplasia,2004,(02):136-142.
  • 7曹崑,张晓鹏,汪宁,单军,崔湧,齐丽萍.MR扩散成像评价宫颈癌放(化)疗早期疗效[J].中国医学影像技术,2009(9):1657-1660. 被引量：22

二级参考文献26

  • 1Chenevert TL,Meyer CR,Moffat BA,et al.Diffusion MRI:a new strategy for assessment of cancer therapeutic efficacy.Mol Imaging,2002,1(4):336-343.
  • 2Hayes C,Padhani AR,Leach MO.Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging.NMR Biomed,2002,15(2):154-163.
  • 3Padhani AR.Functional MRI for anticancer therapy assessment.Eur J Cancer,2002,38(16):2116-2127.
  • 4Naganawa S,Sato C,Kumada H,et al.Apparent diffusion coefficient in cervical cancer of the uterus:comparison with the normal uterine cervix.Eur Radiol,2005,15(1):71-78.
  • 5Nam H,Park W,Huh SJ,et al.The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI.Gynecol Oncol,2007,107(2):320-325.
  • 6Kurek R,Kalogera-Fountzila A,Muskalla K,et al.Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer.Strahlenther Onkol,2003,179(5):292-297.
  • 7Ohara K,Tanaka YO,Oki A,et al.Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy.Radiat Med,2008,26(9):526-532.
  • 8Mayr NA,Yuh WT,Taoka T,et al.Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.AJR Am J Roentgenol,2006,187(1):65-72.
  • 9Ohara K,Oki A,Tanaka YO,et al.Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high-and low-response tumors.Int J Radiat Oncol Biol Phys,2006,64(4):1179-1182.
  • 10Theilmann RJ,Borders R,Trouard TP,et al.Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.Neoplasia,2004,6(6):831-837.

共引文献38

同被引文献9

引证文献2

二级引证文献13

福建医药杂志
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部